Summary:
Peters Medical Research NY, LLC is conducting a Randomized, Double-Blind, Multi-Center, Parallel Group Study to Assess the Efficacy and Safety of PT010 Relative to PT003 and PT009 on COPD Exacerbations over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD
Qualified Participants Must:
• Have an established clinical history of COPD
•
Be a current or former smokers with a history of at least 10 pack-years of cigarette smoking
•
Have a history of exacerbations
Qualified Participants May Receive:
Compensated for time and travel, Close medical attention, and access to new treatment.